DalsnaFinance › IPOs › Burning Rock Biotech › IPO

Burning Rock Biotech Ltd IPO

Completed

Burning Rock Biotech Ltd completed its initial public offering on NASDAQ on June 12, 2020, pricing at $16.50 a share.

Ticker	BNR
Exchange	NASDAQ
Status	Completed
Listing date	June 12, 2020
Offering price	$16.50
Shares offered	13,500,000
Total raised	$223M

The offering

Burning Rock Biotech Ltd sold 13,500,000 shares at $16.50 each on NASDAQ. Multiplied out, that is $222.8 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $223 million total recorded for the deal.

Company coverage

Burning Rock Biotech Ltd — quote, profile and latest news →

Other recent IPOs

First Breach, Inc. · August 12, 2026
Advasa Holdings, Inc. · August 11, 2026
Latigo Biotherapeutics, Inc. · August 4, 2026
BOA Acquisition Corp. II · August 3, 2026
Obsidian Therapeutics, Inc. · August 3, 2026
Attovia Therapeutics, Inc. · July 29, 2026
Game Your Game Inc. · July 27, 2026
Scribe Therapeutics, Inc. · July 21, 2026

Source: SEC EDGAR filings for Burning Rock Biotech Ltd. This page is general information, not investment advice.